The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis
- PMID: 19360466
- PMCID: PMC4951160
- DOI: 10.1007/s10549-009-0389-y
The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis
Abstract
Work loss is a potential adverse consequence of cancer. There is limited research on patterns and correlates of paid work after diagnosis of breast cancer, especially among ethnic minorities. Women with non-metastatic breast cancer diagnosed from June 2005 to May 2006 who reported to the Los Angeles County SEER registry were identified and asked to complete the survey after initial treatment (median time from diagnosis = 8.9 months). Latina and African American women were over-sampled. Analyses were restricted to women working at the time of diagnosis, <65 years of age, and who had complete covariate information (N = 589). The outcome of the study was missed paid work (<or=1 month, >1 month, stopped all together). Approximately 44, 24, and 32% of women missed <or=1 month, >1 month, or stopped working, respectively. African Americans and Latinas were more likely to stop working when compared with Whites [OR for stop working vs. missed <or=1 month: 3.0, 3.4, (P < 0.001), respectively]. Women receiving mastectomy and those receiving chemotherapy were also more likely to stop working, independent of sociodemographic and treatment factors [ORs for stopped working vs. missed <or=1 month: 4.2, P < 0.001; 7.9, P < 0.001, respectively]. Not having a flexible work schedule available through work was detrimental to working [ORs for stopped working 18.9, P < 0.001 after adjusting for sociodemographic and treatment factors]. Many women stop working altogether after a diagnosis of breast cancer, particularly if they are racial/ethnic minorities, receive chemotherapy, or those who are employed in an unsupportive work settings. Health care providers need to be aware of these adverse consequences of breast cancer diagnosis and initial treatment.
Figures


Similar articles
-
Treatment decisions and employment of breast cancer patients: Results of a population-based survey.Cancer. 2017 Dec 15;123(24):4791-4799. doi: 10.1002/cncr.30959. Epub 2017 Oct 9. Cancer. 2017. PMID: 28990155 Free PMC article.
-
Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.J Clin Oncol. 2014 Apr 20;32(12):1269-76. doi: 10.1200/JCO.2013.53.0956. Epub 2014 Mar 24. J Clin Oncol. 2014. PMID: 24663041 Free PMC article.
-
Racial/ethnic differences in job loss for women with breast cancer.J Cancer Surviv. 2011 Mar;5(1):102-11. doi: 10.1007/s11764-010-0152-8. Epub 2010 Oct 9. J Cancer Surviv. 2011. PMID: 20936435 Free PMC article.
-
Racial/ethnic group differences in treatment decision-making and treatment received among older breast carcinoma patients.Cancer. 2006 Feb 15;106(4):957-65. doi: 10.1002/cncr.21680. Cancer. 2006. PMID: 16402372
-
Treatment experiences of Latinas after diagnosis of breast cancer.Cancer. 2017 Aug 15;123(16):3022-3030. doi: 10.1002/cncr.30702. Epub 2017 Apr 11. Cancer. 2017. PMID: 28398629 Free PMC article.
Cited by
-
A review of cancer in U.S. Hispanic populations.Cancer Prev Res (Phila). 2012 Feb;5(2):150-63. doi: 10.1158/1940-6207.CAPR-11-0447. Cancer Prev Res (Phila). 2012. PMID: 22307564 Free PMC article. Review.
-
Return to Work and Work Productivity During the First Year After Cancer Treatment.Front Psychol. 2022 Apr 12;13:866346. doi: 10.3389/fpsyg.2022.866346. eCollection 2022. Front Psychol. 2022. PMID: 35496253 Free PMC article.
-
Roles of PTEN with DNA Repair in Parkinson's Disease.Int J Mol Sci. 2016 Jun 15;17(6):954. doi: 10.3390/ijms17060954. Int J Mol Sci. 2016. PMID: 27314344 Free PMC article. Review.
-
Impact of Cancer on Employment.J Clin Oncol. 2020 Feb 1;38(4):302-309. doi: 10.1200/JCO.19.01856. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804857 Free PMC article. Review. No abstract available.
-
Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.Ann Surg Oncol. 2022 May;29(5):3051-3061. doi: 10.1245/s10434-021-11260-y. Epub 2022 Jan 17. Ann Surg Oncol. 2022. PMID: 35039947 Free PMC article.
References
-
- Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K, Baumgartner KB, Fetherolf J, Reeve BB, Smith AW, et al. Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat. 2007;106(1):85–95. doi: 10.1007/s10549-006-9479-2. - DOI - PMC - PubMed
-
- Maunsell E, Brisson C, Dubois L, Lauzier S, Fraser A. Work problems after breast cancer: an exploratory qualitative study. Psychooncology. 1999;8(6):467–473. doi: 10.1002/(SICI)1099-1611(199911/12)8:6<467::AID-PON400>3.0.CO;2-P. - DOI - PubMed
-
- Kennedy F, Haslam C, Munir F, Pryce J. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care (Engl) 2007;16(1):17–25. doi: 10.1111/j.1365-2354.2007.00729.x. - DOI - PubMed
-
- Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25(1):47–54. doi: 10.1080/07357900601130664. - DOI - PubMed
-
- Bouknight RR, Bradley CJ, Luo Z. Correlates of return to work for breast cancer survivors. J Clin Oncol. 2006;24(3):345–353. doi: 10.1200/JCO.2004.00.4929. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical